TSE:LEA - MedReleaf Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
Previous CloseN/A
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive LEA News and Ratings via Email

Sign-up to receive the latest news and ratings for LEA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolTSE:LEA
CUSIPN/A
WebN/A
PhoneN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

MedReleaf (TSE:LEA) Frequently Asked Questions

What is MedReleaf's stock symbol?

MedReleaf trades on the Toronto Stock Exchange (TSX) under the ticker symbol "LEA."

When is MedReleaf's next earnings date?

MedReleaf is scheduled to release their next quarterly earnings announcement on Tuesday, May, 29th 2018. View Earnings Estimates for MedReleaf.

Has MedReleaf been receiving favorable news coverage?

News articles about LEA stock have been trending very positive this week, Accern reports. The research firm identifies negative and positive news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. MedReleaf earned a coverage optimism score of 0.50 on Accern's scale. They also assigned media stories about the company an impact score of 41.79 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the near future.

How do I buy shares of MedReleaf?

Shares of LEA and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.


MarketBeat Community Rating for MedReleaf (LEA)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  3 (Vote Outperform)
Underperform Votes:  2 (Vote Underperform)
Total Votes:  5
MarketBeat's community ratings are surveys of what our community members think about MedReleaf and other stocks. Vote "Outperform" if you believe LEA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LEA will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

MedReleaf (TSE:LEA) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
1 Wall Street analysts have issued ratings and price targets for MedReleaf in the last 12 months. There are currently 1 buy rating for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyN/AN/AN/A
Consensus Rating Score: 3.00N/AN/AN/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

MedReleaf (TSE:LEA) Consensus Price Target History

Price Target History for MedReleaf (TSE:LEA)

MedReleaf (TSE:LEA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
5/8/2018Beacon SecuritiesReiterated RatingBuyView Rating Details
(Data available from 5/25/2016 forward)

Earnings

MedReleaf (TSE:LEA) Earnings History and Estimates Chart

Earnings by Quarter for MedReleaf (TSE:LEA)

MedReleaf (TSE:LEA) Earnings Estimates

2018 EPS Consensus Estimate: ($0.08)
2019 EPS Consensus Estimate: ($0.18)
2020 EPS Consensus Estimate: $0.38
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181($0.03)($0.03)($0.03)
Q2 20181$0.00$0.00$0.00
Q3 20181($0.01)($0.01)($0.01)
Q4 20182($0.05)($0.03)($0.04)
Q1 20191($0.04)($0.04)($0.04)
Q2 20191($0.04)($0.04)($0.04)
Q3 20191($0.07)($0.07)($0.07)
Q4 20191($0.03)($0.03)($0.03)
Q1 20201$0.00$0.00$0.00
Q2 20201$0.05$0.05$0.05
Q3 20201$0.10$0.10$0.10
Q4 20201$0.23$0.23$0.23

MedReleaf (TSE LEA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/29/2018        
2/13/2018Q3 2018C($0.01)C($0.05)C$11.02 millionC$11.35 millionViewN/AView Earnings Details
11/13/2017Q2 2018C($0.02)C$10.45 millionC$9.82 millionViewN/AView Earnings Details
8/14/2017Q1 2018C($0.01)C$0.02C$10.56 millionC$10.46 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

MedReleaf (TSE:LEA) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

MedReleaf (TSE LEA) Insider Trading and Institutional Ownership History

Insider Trading History for MedReleaf (TSE:LEA)

MedReleaf (TSE LEA) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

MedReleaf (TSE LEA) News Headlines

Source:
DateHeadline
MedReleaf CorpMedReleaf Corp
www.baystreet.ca - May 24 at 3:15 PM
Beacon Securities Reaffirms "Buy" Rating for MedReleaf (LEA)Beacon Securities Reaffirms "Buy" Rating for MedReleaf (LEA)
www.americanbankingnews.com - May 11 at 6:25 PM
Analysts Offer Predictions for MedReleaf Corp.s FY2018 Earnings (LEA)Analysts Offer Predictions for MedReleaf Corp.'s FY2018 Earnings (LEA)
www.americanbankingnews.com - May 11 at 10:20 AM
Medreleaf Corp (LEA) Scheduled to Post Quarterly Earnings on MondayMedreleaf Corp (LEA) Scheduled to Post Quarterly Earnings on Monday
www.americanbankingnews.com - November 6 at 11:28 AM
3 Reasons Marijuana Legalization Could Be Delayed - The Motley Fool Canada3 Reasons Marijuana Legalization Could Be Delayed - The Motley Fool Canada
www.fool.ca - August 21 at 12:36 AM
FY2018 EPS Estimates for Medreleaf Corp Increased by Analyst (LEA)FY2018 EPS Estimates for Medreleaf Corp Increased by Analyst (LEA)
www.americanbankingnews.com - August 17 at 2:04 PM
Clarus Securities Comments on Medreleaf Corps Q2 2018 Earnings (LEA)Clarus Securities Comments on Medreleaf Corp's Q2 2018 Earnings (LEA)
www.americanbankingnews.com - August 16 at 12:14 PM

SEC Filings

MedReleaf (TSE:LEA) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

MedReleaf (TSE LEA) Stock Chart for Friday, May, 25, 2018

Loading chart…

This page was last updated on 5/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.